+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Biopharmaceuticals Market - Global Forecast 2025-2032 - Product Thumbnail Image

Biopharmaceuticals Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 197 Pages
  • Global
From
Antibody Production Market - Global Forecast 2025-2032 - Product Thumbnail Image

Antibody Production Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
Antibody Therapeutics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Antibody Therapeutics Market - Global Forecast 2025-2030

  • Report
  • October 2025
  • 188 Pages
  • Global
From
Marine Derived Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Marine Derived Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
Protein Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Protein Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
From
Chemotherapy Treatment - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 188 Pages
  • Global
From
From
Hedgehog Pathway Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Hedgehog Pathway Inhibitors - Global Strategic Business Report

  • Report
  • October 2025
  • 102 Pages
  • Global
From
Ewing Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Ewing Sarcoma - Global Strategic Business Report

  • Report
  • October 2025
  • 377 Pages
  • Global
From
Adenoid Cystic Carcinoma - Global Strategic Business Report - Product Thumbnail Image

Adenoid Cystic Carcinoma - Global Strategic Business Report

  • Report
  • October 2025
  • 386 Pages
  • Global
From
Angiosarcoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment - Global Strategic Business Report

  • Report
  • October 2025
  • 390 Pages
  • Global
From
From
Combination Antibody Therapy - Global Strategic Business Report - Product Thumbnail Image

Combination Antibody Therapy - Global Strategic Business Report

  • Report
  • October 2025
  • 196 Pages
  • Global
From
Gynecological Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Gynecological Cancer Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 193 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • October 2025
  • 224 Pages
  • Global
From
Immune Checkpoint Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Immune Checkpoint Inhibitors - Global Strategic Business Report

  • Report
  • October 2025
  • 194 Pages
  • Global
From
Malignant Mesothelioma - Global Strategic Business Report - Product Thumbnail Image

Malignant Mesothelioma - Global Strategic Business Report

  • Report
  • October 2025
  • 193 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 193 Pages
  • Global
From
Loading Indicator